{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:16:24Z","timestamp":1768968984188,"version":"3.49.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This study aimed to evaluate the potential of solid lipid nanoparticles (SLNs) of paclitaxel (PTX) modified with a 2-hydroxypropyl-\u03b2-cyclodextrin system to enhance cellular accumulation of PTX into p-glycoprotein (p-gp)-expressing cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The PTX-loaded-SLNs consisted of lipid (stearic acid) and surfactants (lecithin and poloxamer 188) and were then modified with 2-hydroxypropyl-\u03b2-cyclodextrin by a sonication method.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>In terms of cytotoxicity, PTX-loaded SLNs modified with 2-hydroxypropyl-\u03b2-cyclodextrin showed higher cytotoxicity than other formulations. In particular, the cellular uptake of PTX from PTX-loaded SLNs modified with 2-hydroxypropyl-\u03b2-cyclodextrin was about 5.8- and 1.5-fold higher than that from PTX solution and unmodified PTX-loaded SLNs in MCF-7\/ADR cells, respectively. After a 4-h incubation, clear fluorescence images inside cells were observed over time. When PTX-loaded SLNs modified with 2-hydroxypropyl-\u03b2-cyclodextrin were incubated with MCF-7\/ADR cells for 4 h, cellular uptake of PTX increased 1.7-fold versus that of PTX in the presence of verapamil.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results suggest that optimized SLNs modified with 2-hydroxypropyl-\u03b2-cyclodextrin may have potential as an oral drug delivery system for PTX.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.2042-7158.2012.01578.x","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T10:49:12Z","timestamp":1344854952000},"page":"72-78","source":"Crossref","is-referenced-by-count":37,"title":["2-Hydroxypropyl-<i>\u03b2<\/i>-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells"],"prefix":"10.1093","volume":"65","author":[{"given":"Jong-Suep","family":"Baek","sequence":"first","affiliation":[{"name":"College of Pharmacy and Institute of Drug Research and Development, Chungnam National University , Yuseong-gu, Daejeon,","place":["South Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheong-Weon","family":"Cho","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Institute of Drug Research and Development, Chungnam National University , Yuseong-gu, Daejeon,","place":["South Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,1,1]]},"reference":[{"key":"2024103109154184100_cit1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/02652040802379902","article-title":"Studies on paclitaxel-loaded glyceryl monostearate nanoparticles","volume":"26","author":"Shenoy","year":"2009","journal-title":"J Microencapsul"},{"key":"2024103109154184100_cit2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1023\/A:1018943021705","article-title":"A mixed micellar formulation suitable for the parenteral administration of taxol","volume":"11","author":"Alkan-Onyuksel","year":"1994","journal-title":"Pharm Res"},{"key":"2024103109154184100_cit3","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1023\/A:1011901921995","article-title":"Development of novel chitosan derivatives as micellar carriers of taxol","volume":"15","author":"Miwa","year":"1998","journal-title":"Pharm Res"},{"key":"2024103109154184100_cit4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1023\/A:1018994111594","article-title":"Novel taxol formulations: preparation and characterization of taxol-containing liposomes","volume":"11","author":"Sharma","year":"1994","journal-title":"Pharm Res"},{"key":"2024103109154184100_cit5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1023\/A:1016483406511","article-title":"A new parenteral emulsion for the administration of taxol","volume":"4","author":"Tarr","year":"1987","journal-title":"Pharm Res"},{"key":"2024103109154184100_cit6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization","volume":"30","author":"Schwarz","year":"1994","journal-title":"J Control Release"},{"key":"2024103109154184100_cit7","first-page":"670","article-title":"Safety and efficiacy of the multidrug resistance inhibitor in combination with paclitaxel in advanced breast cancer refractory to paclitaxel","volume":"8","author":"Toppmeyer","year":"2002","journal-title":"Clin Cancer Res"},{"key":"2024103109154184100_cit8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","article-title":"Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor","volume":"103","author":"Lee","year":"2005","journal-title":"J Control Release"},{"key":"2024103109154184100_cit9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drup.2011.01.003","article-title":"Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance","volume":"14","author":"Shapira","year":"2011","journal-title":"Drug Resist Updat"},{"key":"2024103109154184100_cit10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0378-5173(02)00080-7","article-title":"Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin","volume":"238","author":"Cavalli","year":"2002","journal-title":"Int J Pharm"},{"key":"2024103109154184100_cit11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.addr.2007.04.010","article-title":"Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system","volume":"59","author":"Chattopadhyay","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"2024103109154184100_cit12","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2012.1086","article-title":"Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl beta cyclodextrin as oral delivery systems","author":"Baek","year":"2012","journal-title":"Int J Mol Med"},{"key":"2024103109154184100_cit13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2006.12.033","article-title":"Difunctional pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and pluronic-mediated overcoming multidrug resistance in tumor cell lines","volume":"337","author":"Wang","year":"2007","journal-title":"Int J Pharm"},{"key":"2024103109154184100_cit14","first-page":"517","article-title":"Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes","volume":"1768","author":"Vandenbroucke","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"2024103109154184100_cit15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejps.2010.08.004","article-title":"Synthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system","volume":"41","author":"Li","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"2024103109154184100_cit16","first-page":"374","article-title":"Quantitation of neutrophil phagocytosis, using fluorescent latex beads. Correlation of microscopy and flow cytometry","volume":"98","author":"Dunn","year":"1981","journal-title":"J Lab Clin Med"},{"key":"2024103109154184100_cit17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1211\/0022357011775190","article-title":"Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium","volume":"53","author":"Foster","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"2024103109154184100_cit18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3835(98)00280-8","article-title":"The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line","volume":"135","author":"Huang","year":"1999","journal-title":"Cancer Lett"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.2012.01578.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/65\/1\/72\/60251992\/j.2042-7158.2012.01578.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/65\/1\/72\/60251992\/j.2042-7158.2012.01578.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:20:24Z","timestamp":1730366424000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/65\/1\/72\/6132970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,1]]},"published-print":{"date-parts":[[2013,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01578.x","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,1]]},"published":{"date-parts":[[2013,1,1]]}}}